Joshua Sharlin, Ph.D. Launches New Shareholder Lawsuit Expert Witness Service

Joshua Sharlin, Ph.D., has launched a new Shareholder Lawsuit Expert Witness service. Leveraging decades of FDA, regulatory, and product development expertise, Dr. Sharlin provides expert support in cases alleging that a company’s FDA-related actions or decisions contributed to a preventable loss in shareholder value.

-- Joshua Sharlin, Ph.D. founder of Sharlin Consulting, has now launched a range of shareholder lawsuit expert witness services for attorneys, bringing experience with the entire lifecycle of product development. Dr. Sharlin also brings a wide range of expertise involving pharmaceuticals, biologics, and medical devices, and has served as an FDA regulatory expert witness and consultant in a wide range of legal matters.

Dr. Sharlin now offers his expertise in cases involving allegations that a company’s FDA-related actions or decisions led to an avoidable decline in shareholder value. He brings hands-on work throughout the entire life cycle of product development, from early development of a regulatory strategy, clinical trial planning and execution through regulatory submission and post-market safety surveillance. His track record includes writing expert reports, being deposed, (20+ times) and testifying (5 times) in court and arbitration, with no opinions excluded under the Daubert challenge.

Bringing over a decade of expert witness engagement experience, Dr. Sharlin supports attorneys in a wide range of high-stakes cases, including:

  • Wrongful death or serious injury
  • Patent and trade secret litigation
  • Insurance disputes tied to FDA labeling or compliance
  • Contract and M&A disputes involving regulatory obligations
  • Stock fraud involving FDA-regulations and compliance
  • Off-label promotion, data integrity violations, and criminal charges

Having worked as an FDA drug reviewer, Ph.D.-level biologist, and seasoned industry consultant, Dr. Sharlin is able to provide clear, courtroom-ready analyses of product lifecycles, including FDA submissions, clinical data, and software integrity. With experience in more than 50 litigation matters, he brings the ability to translate complex technical and regulatory issues into clear, persuasive insights and to apply that expertise to expert reports and testimony.

With his new shareholder lawsuit expert witness services, Dr. Sharlin aims to help attorneys in cases when a company’s failure to follow required regulatory steps, misrepresentation of product or process integrity, or deficient oversight is alleged to have contributed to a significant decline in stock price. His knowledge in the field allows Dr. Sharlin to analyze how and when failures in judgement or process occurred, and how they could have and should have been avoided.

Attorneys who require independent, experience-backed expert opinions on shareholder issues are encouraged to visit his website to learn more about how Dr. Sharlin can support their litigation strategy and strengthen their cases.

For more information about Sharlin Consulting, LLC., use the contact details below:

Contact Info:
Name: Joshua Sharlin, Ph.D.
Email: Send Email
Organization: Sharlin Consulting, LLC.
Phone: (410) 231-8900
Website: https://sharlinconsulting.com/

Release ID: 89173361

Should there be any problems, inaccuracies, or doubts arising from the content provided in this press release that require attention or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is central to our commitment.

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.44
+3.35 (1.52%)
AAPL  263.45
+3.87 (1.49%)
AMD  251.14
+16.15 (6.87%)
BAC  52.59
+0.83 (1.60%)
GOOG  261.44
+7.72 (3.04%)
META  739.08
+5.08 (0.69%)
MSFT  524.76
+4.20 (0.81%)
NVDA  186.49
+4.33 (2.38%)
ORCL  284.76
+4.69 (1.67%)
TSLA  432.38
-16.61 (-3.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.